🇺🇸 FDA
Patent

US 7375185

Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 7375185 (Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61P, A61P9/04